These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 27316919)

  • 1. The value of
    van Rossum PSN; Fried DV; Zhang L; Hofstetter WL; Ho L; Meijer GJ; Carter BW; Court LE; Lin SH
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):71-80. PubMed ID: 27511188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy.
    Hsu CY; Wang CW; Kuo CC; Chen YH; Lan KH; Cheng AL; Kuo SH
    Oncotarget; 2017 Jan; 8(5):7921-7934. PubMed ID: 27974702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
    Collarino A; Feudo V; Pasciuto T; Florit A; Pfaehler E; de Summa M; Bizzarri N; Annunziata S; Zannoni GF; de Geus-Oei LF; Ferrandina G; Gambacorta MA; Scambia G; Boellaard R; Sala E; Rufini V; van Velden FH
    J Nucl Med; 2024 Jun; 65(6):962-970. PubMed ID: 38548352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of F-18 FDG PET/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis.
    Lee SW; Jeong SY; Kim K; Kim SJ
    Ann Nucl Med; 2021 Sep; 35(9):1038-1047. PubMed ID: 34109555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pathological response using 18F FDG PET/CT derived metabolic parameters in locally advanced breast cancer patients.
    Abd El-Gaid S; AbdelHafez MN; Mohamed G; Elazab MSS; Elahmadawy MA
    Nucl Med Commun; 2022 Mar; 43(3):292-303. PubMed ID: 34908020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of basal 18F-FDG PET/CT maximum standard uptake value and maximum standard uptake change in predicting pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
    Akdeniz N; Kömek H; Küçüköner M; Kaplan MA; Urakçi Z; Oruç Z; Işikdoğan A
    Nucl Med Commun; 2021 Mar; 42(3):315-324. PubMed ID: 33315727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT metabolism multi-parameter prediction of chemotherapy efficacy in locally progressive gastric cancer.
    Jin L; Zhang L; Fu L; Song F; Cheng A
    Ann Nucl Med; 2024 Jun; 38(6):475-482. PubMed ID: 38536655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental detection by
    Mangas Losada M; García Megías I; Boulvard Chollet X; Romero Robles L; Garrastachu Zumarán P; Ramírez Lasanta R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):115-116. PubMed ID: 38331247
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of the maximum standardized uptake value on positron emission tomography to predict treatment response and outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Tsuneki T; Matsuda T; Sawada R; Hasegawa H; Yamashita K; Koterazawa Y; Harada H; Urakawa N; Goto H; Kanaji S; Kakeji Y
    Surg Today; 2024 Jun; ():. PubMed ID: 38878069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Biomarkers for Response to Preoperative Chemoradiation in Locally Advanced Rectal Cancer with Genetic Algorithm-Based Gene Selection.
    Mohseni N; Ghaniee Zarich M; Afshar S; Hosseini M
    J Gastrointest Cancer; 2023 Sep; 54(3):937-950. PubMed ID: 36534304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.
    San-Román-Gil M; Martínez-Delfrade I; Albarrán-Fernández V; Guerrero-Serrano P; Pozas-Pérez J; Chamorro-Pérez J; Rosero-Rodríguez D; Sotoca-Rubio P; Barrill-Corpa AM; Alia-Navarro V; González-Merino C; García-de-Quevedo-Suero C; López V; Ruz-Caracuel I; Perna-Monroy C; Ferreiro-Monteagudo R
    Front Immunol; 2024; 15():1352262. PubMed ID: 38361927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Factors of Complete Pathological Response in Locally Advanced Rectal Cancer.
    Latif A; Shirkhoda M; Rouhollahi MR; Nemati S; Yahyazadeh SH; Zendehdel K; Soroush AR; Yaghoobi Notash A
    Middle East J Dig Dis; 2022 Oct; 14(4):443-451. PubMed ID: 37547496
    [No Abstract]   [Full Text] [Related]  

  • 13. MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer.
    Gao PF; Lu N; Liu W
    Front Oncol; 2023; 13():1031581. PubMed ID: 36741013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is interim
    Etchebehere E; Brito AE; Kairemo K; Rohren E; Araujo J; Macapinlac H
    Radiol Bras; 2019; 52(1):33-40. PubMed ID: 30804613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy.
    Farrugia MK; Wen S; Jacobson GM; Salkeni MA
    World J Nucl Med; 2018; 17(4):275-280. PubMed ID: 30505226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer.
    Koo PJ; Kim SJ; Chang S; Kwak JJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):e213-e219. PubMed ID: 27316919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients.
    Kim SJ; Koo PJ; Chang S
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):723-31. PubMed ID: 26891957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
    Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Kim SJ; Chang S
    Clin Nucl Med; 2015 Dec; 40(12):930-5. PubMed ID: 26204222
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.